![]() |
|
searchpremium serviceseventsdirectory servicesadvertisingcustomer care |
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients WeylChem Hunts for ‘Sizable’ Deals to Further Increase Sales10:36 AM MST | February 19, 2008 | Alex Scott Private equity-owned chemicals manufacturer WeylChem (Frankfurt) is seeking major acquisitions as part of a strategy to maintain strong double-digit sales growth, the company told CW at the Informex specialty and fine chemicals expo, held recently in New Orleans. WeylChem’s sales grew 70% in each of the past two years largely through acquisitions, to reach about €600 million ($873 million) in 2007. The company’s sales to the pharmaceuticals sector are about €250 million/year, making WeylChem a top-20 custom fine chemical player. Maintaining... This information is only available to Chemical Week subscribers. Forgot your user ID or password?
|
Not an IHS Chemical Week
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|